| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | +9.9% | +486.1% |
| R&D Expense | $44.0M | +6.3% | +9.0% |
| SG&A Expense | $11.2M | -14.6% | -20.5% |
| Operating Income | -$54.0M | -1.1% | +0.5% |
| Net Income | -$50.6M | +3.8% | +3.7% |
| EPS (Basic) | -$0.32 | +22.0% | +27.3% |
| EPS (Diluted) | -$0.32 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $71.4M | +32.7% | -39.5% |
| Current Assets | $231.4M | +90.8% | -6.0% |
| Total Assets | $385.0M | +38.0% | +15.7% |
| Current Liabilities | $35.0M | +2.7% | -7.5% |
| Total Liabilities | $223.2M | +2.3% | +55.8% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$125.3M | — | — |
| Capital Expenditures | $4.2M | — | — |
| Investing Cash Flow | -$137.1M | — | — |
| Financing Cash Flow | $150.9M | — | — |
| Free Cash Flow | -$129.5M | — | — |
| +22.0% |
| +27.3% |
| $161.8M |
| +165.9% |
| -14.6% |